<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0032962" disease_type="Disease or Syndrome" abbrv="">Complications of pregnancy</z:e>, such as <z:e sem="disease" ids="C0032914" disease_type="Disease or Syndrome" abbrv="PEE|PREG1|PEE1">preeclampsia</z:e>, <z:hpo ids='HP_0011419'>placental abruption</z:hpo>, fetal <z:hpo ids='HP_0001510'>growth retardation</z:hpo>, still-birth and fetal <z:hpo ids='HP_0011420'>death</z:hpo> are associated with an increased frequency of pro-thrombotic abnormalities </plain></SENT>
<SENT sid="1" pm="."><plain>We describe a case of <z:e sem="disease" ids="C0341950,C0156669" disease_type="Disease or Syndrome" abbrv="">severe preeclampsia</z:e> and multiple <z:hpo ids='HP_0011416'>placental infarctions</z:hpo> in a 28-year-old woman at 31 weeks' gestation </plain></SENT>
<SENT sid="2" pm="."><plain>Despite a negative personal history for venous <z:hpo ids='HP_0001907'>thromboembolism</z:hpo>, coagulation screening for <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> detected an isolated <z:hpo ids='HP_0001976'>antithrombin III deficiency</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>In view of the high prevalence of pro-thrombotic complications, laboratory screening for <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> would be advantageous in women with <z:e sem="disease" ids="C0032962" disease_type="Disease or Syndrome" abbrv="">complicated pregnancies</z:e>, to ensure adequate management in high-risk situations, as suggested by larger-scale clinical investigations </plain></SENT>
</text></document>